NCT05050279View on ClinicalTrials.gov

A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

January 4, 2022

Study Completion Date

January 4, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Delgocitinib capsule

oral capsule

DRUG

Placebo capsule

oral capsule

Trial Locations (1)

LS2 9LH

Labcorp Clinical Research Unit (CRU) Ltd, Springfield House, Hyde Street,, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY